Scholarlink

<p>Small-molecule kinase modulators are an expanding class of compounds with broad impact on biology and medicine. However, although currently 100 inhibitors are FDA approved, many disease-linked kinases remain intractable to conventional therapeutic approaches. Key challenges include selectivity, modulation of scaffolding functions and overcoming drug resistance. Here, we review the expanding toolkit for kinase modulation, comparing traditional ATP-site inhibitors with emerging classes of allosteric modulators and proximity-inducing molecules such as molecular glues and heterobivalent degraders. Through representative case studies, we illustrate how these novel chemical approaches can overcome the limitations of traditional inhibitors and discuss future innovations poised to deliver the next generation of kinase-targeted therapies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies

  • 期刊论文

  • 发表日期：

    2026年4月28日

查看全文
  • Joachim Rudolph,
  • Klaus P. Hoeflich,
  • Arvin C. Dar

摘要

Small-molecule kinase modulators are an expanding class of compounds with broad impact on biology and medicine. However, although currently 100 inhibitors are FDA approved, many disease-linked kinases remain intractable to conventional therapeutic approaches. Key challenges include selectivity, modulation of scaffolding functions and overcoming drug resistance. Here, we review the expanding toolkit for kinase modulation, comparing traditional ATP-site inhibitors with emerging classes of allosteric modulators and proximity-inducing molecules such as molecular glues and heterobivalent degraders. Through representative case studies, we illustrate how these novel chemical approaches can overcome the limitations of traditional inhibitors and discuss future innovations poised to deliver the next generation of kinase-targeted therapies.